Legend Biotech Corp is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
LEGN is expected to report earnings to fall 57.30% to -11 cents per share on August 11
Q2'25
Est.
$-0.12
Q1'25
Missed
by $0.06
Q4'24
Beat
by $0.09
Q3'24
Missed
by $0.01
Q2'24
Beat
by $0.24
The last earnings report on May 13 showed earnings per share of -27 cents, missing the estimate of -20 cents. With 387.78K shares outstanding, the current market capitalization sits at 6.89B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LEGN showed earnings on May 13, 2025. You can read more about the earnings report here.